StockNews.com assumed coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock. Separately, Zacks Investment Research raised shares of Galectin Therapeutics from a “sell” rating to a “hold” rating in a report on Wednesday, January 19th. NASDAQ:GALT opened at $1.61 […]
AE Wealth Management LLC cut its position in shares of Invesco Ultra Short Duration ETF (NYSEARCA:GSY – Get Rating) by 67.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 7,466 shares of the company’s stock after selling 15,332 shares during the quarter. AE Wealth Management LLC’s holdings in Invesco Ultra Short Duration […]
Solstein Capital LLC cut its holdings in Tesla, Inc. (NASDAQ:TSLA – Get Rating) by 14.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 182 shares of the electric vehicle producer’s stock after selling 30 shares during the period. […]
Balasa Dinverno & Foltz LLC increased its position in shares of SPDR Portfolio Emerging Markets ETF (NYSEARCA:SPEM – Get Rating) by 12.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 11,174 shares of the company’s stock after acquiring an additional 1,263 shares […]
Aspen Investment Management Inc cut its stake in Invesco BulletShares 2023 High Yield Corporate Bond ETF (NYSEARCA:BSJN – Get Rating) by 17.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,700 shares of the company’s stock after selling 1,800 shares during […]